InsidersTradesSigma
Total declarations
Company
▲ Purchases (13 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
13
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
+27.1%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Trieu Vuong. Officer active across 1 company, notably Oncotelic Therapeutics, Inc.. In total, 14 disclosures have been published. Split: 13 buys · 0 sell. Total volume traded: €73k. Activity tracked since 25 August 2022. The latest transaction was filed on 10 July 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Trieu Vuong
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
104,000 shares@ US$0.0050.6% of flowCommon StockSEC:0001641172-25-018620:0
Canonical exit: 8 Oct 2025 (T+90)
183,066 shares@ US$0.0286.8% of flowCommon StockSEC:0001493152-25-004486:0
Canonical exit: 29 Apr 2025 (T+90)
298,499 shares@ US$0.028911.4% of flowCommon StockSEC:0001493152-24-047762:0
Canonical exit: 20 Feb 2025 (T+90)
500,000 shares@ US$0.0212.5% of flowCommon StockSEC:0001493152-24-033939:0
Canonical exit: 21 Nov 2024 (T+90)
425,000 shares@ US$0.02111.4% of flowCommon StockSEC:0001493152-23-023015:0
Canonical exit: 27 Sept 2023 (T+90)
100,000 shares@ US$0.0263.3% of flowCommon StockSEC:0001493152-23-021800:0
Canonical exit: 14 Sept 2023 (T+90)
400,000 shares@ US$0.032616.7% of flowCommon StockSEC:0001493152-23-021563:0
Canonical exit: 12 Sept 2023 (T+90)
126,888 shares@ US$0.03415.6% of flowCommon StockSEC:0001493152-23-019557:0
Canonical exit: 24 Aug 2023 (T+90)
100,000 shares@ US$0.0455.7% of flowCommon StockSEC:0001493152-23-015195:0
Canonical exit: 31 Jul 2023 (T+90)
120,000 shares@ US$0.057.9% of flowCommon StockSEC:0001493152-22-034663:0
Canonical exit: 6 Mar 2023 (T+90)
70,000 shares@ US$0.087.6% of flowCommon StockSEC:0001493152-22-033681:0
Canonical exit: 20 Feb 2023 (T+90)
20,000 shares@ US$0.0682.0% of flowCommon StockSEC:0001493152-22-026963:0
Canonical exit: 25 Dec 2022 (T+90)
80,000 shares@ US$0.0829.1% of flowCommon StockSEC:0001493152-22-024234:0
Canonical exit: 23 Nov 2022 (T+90)
74,455,719 sharesCommon StockSEC:0001493152-21-017106:0
14 of 14 declarations
About Trieu Vuong
Trieu Vuong is a declarant. He has filed 14 forms in total, and the 14 sampled filings cover acquisitions in Oncotelic Therapeutics, Inc. between 2021-07-16 and 2025-07-10, with buy volume of EUR 72503 and no sell volume.
